Cargando…
Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849496/ http://dx.doi.org/10.1016/j.jaci.2020.12.048 |